Terazosin (Page 7 of 7)

PACKAGE LABEL

Label Image for 53808-1056 1mg

Label Image for 1mgLabel Image for 1mg
TERAZOSIN terazosin hydrochloride capsule
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:53808-1056(NDC:59746-383)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TERAZOSIN HYDROCHLORIDE (TERAZOSIN) TERAZOSIN 1 mg
Inactive Ingredients
Ingredient Name Strength
FERROSOFERRIC OXIDE
GELATIN
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
SODIUM LAURYL SULFATE
TITANIUM DIOXIDE
STARCH, CORN
COLLOIDAL SILICON DIOXIDE
Product Characteristics
Color GRAY (Gray opaque) Score no score
Shape CAPSULE Size 16mm
Flavor Imprint Code TL383
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:53808-1056-2 60 CAPSULE (CAPSULE) in 1 BLISTER PACK None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA075317 11/01/2014
Labeler — State of Florida DOH Central Pharmacy (829348114)
Establishment
Name Address ID/FEI Operations
State of Florida DOH Central Pharmacy 829348114 repack (53808-1056)

Revised: 01/2015 State of Florida DOH Central Pharmacy

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2021. All Rights Reserved.